Etodolac
Who holds supplier records for Etodolac? 13 organisations hold a current record for Etodolac: an active US FDA Type II Drug Master File or a CEP. A further 8 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), Israel (2), China (2), Poland (1) and 2 other countries (2); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Etodolac: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/etodolac
Reading the evidence
- 13 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 7 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (13)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Etodolac. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 27512, 21449, 24868 · latest filing Sept 2013
- KREATIVE ORGANICS PRIVATE LTDIndiaCEPActive DMF 24422 · latest filing Dec 2010
- Taro Pharmaceutical Industries Ltd.IsraelCEP Company GMP cert on recordActive DMF 15339 · latest filing Apr 2001
- Zakłady Farmaceutyczne Polpharma S.A.PolandCEP Company GMP cert on recordActive DMF 11405 · latest filing Mar 1995
- Zhejiang Chiral Medicine Chemicals Co., Ltd.ChinaCEPActive DMF 16789 · latest filing Aug 2003
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 23688 · latest filing Apr 2010
- AMSA SPAItalyActive DMF 11359 · latest filing Feb 1995
- Emcure Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 25808 · latest filing Mar 2012
- TAPI NL BVNetherlandsActive DMF 11766 · latest filing Dec 1995
- ULKAR KIMYA SANAYII VE TICARET ASActive DMF 24936 · latest filing May 2011
- FLEMING LABORATORIES LTDIndiaCEP Company GMP cert on recordInactive DMF 31967 · latest filing Nov 2017
- Teva Pharmaceutical Industries Ltd.IsraelCEP Company GMP cert on record
- Zhejiang Bamboo Pharmaceuticals Co.,LtdChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (9)
Certificates of Suitability on the EDQM register for Etodolac, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2008-175 - Rev 05 Etodolac | Sept 2026 | — |
| ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. Shaoxing | CN | CEP 2025-257 - Rev 00 Etodolac, Standard and micronised | Apr 2026 | — |
| ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański | PL | CEP 2013-134 - Rev 04 Etodolac, Micronised, non-micronised | Jan 2026 | Inspected Jul 2026 Poland |
| TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa Bay | IL | CEP 2004-082 - Rev 07 Etodolac, Micronised | May 2025 | Inspected Feb 2025 Israel |
| ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. Hangzhou | CN | CEP 2009-338 - Rev 03 Etodolac, Micronised, non-micronised | Oct 2024 | — |
| KREATIVE ORGANICS PRIVATE LIMITED Hyderabad | IN | CEP 2014-131 - Rev 01 Etodolac | Aug 2024 | — |
| FLEMING LABORATORIES LIMITED Nawabpet Village | IN | R1-CEP 2015-180 - Rev 00 Etodolac | May 2023 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R1-CEP 2017-017 - Rev 00 Etodolac | Jan 2023 | — |
| TEVA PHARMACEUTICAL INDUSTRIES LTD. Petach Tikva | IL | R1-CEP 2000-331 - Rev 06 Etodolac | Apr 2014 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (8)
Organisations whose Type II DMFs for Etodolac are no longer active. These show a past filing, not current supply.
Show all 8 historical records
- YANGZHOU PHARMACEUTICAL CO LTDInactive DMF 21578 · filed Apr 2008
- CHEMSOURCE CORPInactive DMF 14298 · filed Jul 1999
- RANBAXY PHARMACEUTICALS INCInactive DMF 12618 · filed Aug 1997
- Italy · Inactive DMF 11740 · filed Nov 1995
- Spain · Inactive DMF 9529 · filed Jan 1992
- LONZA AGInactive DMF 5795 · filed Apr 1985
- UPJOHN COInactive DMF 5383 · filed Jun 1984
- LEDERLE LABORATORIES DIV AMERICAN CYANAMID COInactive DMF 5346 · filed May 1984
Overview
Etodolac is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL622).
Chemical identity
- IUPAC name
- 2-(1,8-diethyl-4,9-dihydro-3H-pyrano[3,4-b]indol-1-yl)acetic acid
- Canonical SMILES
- CCC1=C2C(=CC=C1)C3=C(N2)C(OCC3)(CC)CC(=O)O
- InChIKey
- NNYBQONXHNTVIJ-UHFFFAOYSA-N
- Synonyms
- AY-24,236, AY-24-236, AY-24236, Ebretin, Eccoxolac, Edolan, Etodolac, Etodolaco, Etodolic acid, Etolyn, Etopan xl, Flancox
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
- Mechanism of action
- Cyclooxygenase Inhibitors
- Chemical structure
- Non-Steroidal
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Etodolac?
13 organisations hold an active US FDA Type II Drug Master File or a CEP for Etodolac: Ipca Laboratories Limited (India), KREATIVE ORGANICS PRIVATE LTD (India), Taro Pharmaceutical Industries Ltd. (Israel), Zakłady Farmaceutyczne Polpharma S.A. (Poland), Zhejiang Chiral Medicine Chemicals Co., Ltd. (China), Zydus Lifesciences Limited (India), AMSA SPA (Italy) and Emcure Pharmaceuticals Limited (India), and 5 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Etodolac Drug Master Files are active?
Ipca Laboratories Limited (DMF 27512, 21449), KREATIVE ORGANICS PRIVATE LTD (DMF 24422), Taro Pharmaceutical Industries Ltd. (DMF 15339), Zakłady Farmaceutyczne Polpharma S.A. (DMF 11405), Zhejiang Chiral Medicine Chemicals Co., Ltd. (DMF 16789), Zydus Lifesciences Limited (DMF 23688), AMSA SPA (DMF 11359) and Emcure Pharmaceuticals Limited (DMF 25808) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Etodolac records mean?
8 organisations have only inactive Type II DMFs for Etodolac. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Etodolac have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Etodolac on the EDQM register, including IPCA LABORATORIES LIMITED Mumbai (IN), ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. Shaoxing (CN), ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański (PL), TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa Bay (IL), ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. Hangzhou (CN) and KREATIVE ORGANICS PRIVATE LIMITED Hyderabad (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Etodolac supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Etodolac?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.